Abiomed Inc.
22 Cherry Hill Drive
Danvers,
MA 01923
United States - Map
Phone: 978-777-5410
Fax: 978-777-8411
Web Site: http://www.abiomed.com
| Abiomed, Inc. and its subsidiaries manufacture and sell medical devices in circulatory support that offer a continuum of care in heart recovery to acute heart failure patients. It offers various disposable products for the surgery suite, which comprise BVS 5000 blood pump and AB5000 ventricle for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis; integrated cannula system that connects the ventricle or blood pump to the heart and an associated artery; and Impella LD that provides temporary left ventricular assist devices support for recovery from post-cardiotomy hemodynamic instability and cardiogenic shock. The company also provides disposable products for the cardiac catheterization lab and the surgery suite that include Impella 2.5 and 5.0 catheters, which are percutaneous micro heart pumps with integrated motors and sensors for use in interventional cardiology and heart surgery; and IAB, a percutaneous intra-aortic balloon used to support various prophylactic, pre-shock, and profound shock conditions. In addition, it offers driver console products, such as AB5000 console for BVS 5000 blood pump and AB5000 ventricle; mobile pump consoles for Impella products; iPulse console, a multi-purpose driver console for IAB, AB5000, BVS 5000, and other manufacturersÂ’ IABs; and portable discharge driver for AB5000 for in-hospital and out-of-hospital patients. Further, Abiomed provides AbioCor implantable replacement heart, a self-contained artificial heart for severe biventricular heart failure. It sells its products through direct sales representatives and clinical support personnel in the United States, Germany, France, the United Kingdom, and Ireland; and internationally. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Michael R. Minogue , 41
Chairman, Chief Exec. Officer, Pres, Member of Special Stock Option Committee and Member of Exec. Committee |
$
740.00K |
$
272.00K | Mr. Robert L. Bowen , 59
Chief Financial Officer, Principal Accounting Officer, VP and Treasurer |
$
110.00K |
$
0 | Dr. David M. Weber Ph.D., 48
Chief Operating Officer |
$
360.00K |
$
0 | Mr. William J. Bolt , 57
Sr. VP of Global Quality Regulatory and Engineering |
$
334.00K |
$
391.00K | Mr. Andrew J. Greenfield , 36
VP of Healthcare Solutions |
$
261.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
